“Cannabis sativa (cannabis) produces a resin that is valued for its psychoactive and medicinal properties.
Despite being the foundation of a multi-billion dollar global industry, scientific knowledge and research on cannabis is lagging behind compared to other high-value crops. This is largely due to legal restrictions that have prevented many researchers from studying cannabis, its products, and their effects in humans.
Cannabis resin contains hundreds of different terpene and cannabinoid metabolites.
Our understanding of the genomic and biosynthetic systems of these metabolites in cannabis, and the factors that affect their variability, is rudimentary. As a consequence, there is concern about lack of consistency with regard to the terpene and cannabinoid composition of different cannabis ‘strains’.
Likewise, claims of some of the medicinal properties attributed to cannabis metabolites would benefit from thorough scientific validation.”